Evidence map›Paper›PMID 41801860›Full record

ArticlePloS one2026

Racial differences in people living with HIV and Heart Failure: Insight from New York City health and hospitals HIV Heart Failure Cohort.

Pawel Borkowski, Luca Biavati, Natalia Nazarenko, Matthew Parker, Amrin Kharawala, Coral Vargas-Pena, Shivang Bhakta, Ishmum Chowdhury, Joshua Bock, Vibhor Garg and 3 more

Abstract read
In one paragraph

Article in PloS one, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. Review
  2. Review
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors.

Pawel BorkowskiInternal Medicine Department, NYC Health and Hospitals/Jacobi, Bronx, New York.ORCID https://orcid.org/0000-0001-9233-6545
Luca BiavatiInternal Medicine Department, NYC Health and Hospitals/Jacobi, Bronx, New York.
Natalia NazarenkoInternal Medicine Department, NYC Health and Hospitals/Jacobi, Bronx, New York.
Matthew ParkerInternal Medicine Department, NYC Health and Hospitals/Jacobi, Bronx, New York.
Amrin KharawalaInternal Medicine Department, NYC Health and Hospitals/Jacobi, Bronx, New York.
Coral Vargas-PenaInternal Medicine Department, NYC Health and Hospitals/Jacobi, Bronx, New York.
Shivang BhaktaInternal Medicine Department, NYC Health and Hospitals/Jacobi, Bronx, New York.
Ishmum ChowdhuryInternal Medicine Department, NYC Health and Hospitals/Jacobi, Bronx, New York.
Joshua BockInternal Medicine Department, NYC Health and Hospitals/Jacobi, Bronx, New York.
Vibhor GargInternal Medicine Department, NYC Health and Hospitals/Jacobi, Bronx, New York.
Robert FaillaceInternal Medicine Department, NYC Health and Hospitals/Jacobi, Bronx, New York.
Leonidas PalaiodimosInternal Medicine Department, NYC Health and Hospitals/Jacobi, Bronx, New York.
Yi-Yun ChenInternal Medicine Department, NYC Health and Hospitals/Jacobi, Bronx, New York.ORCID https://orcid.org/0009-0002-6762-6342

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundRacial disparities, an imbalance between the treatment of racial groups, in healthcare significantly affect the prognosis and treatment outcomes for people living with HIV (PLHIV) and heart failure (HF). The complexity of racial disparities in health care is exacerbated when social determinants of health (SDoH). Utilizing the New York City Health and Hospitals HIV Heart Failure (NYC 4H) cohort, one of the largest public health providers in New York City, this study aims to describe the epidemiological characteristics, treatment, and mortality differences among various racial groups in patients living with HIV (PLHIV) and HF.

methodsThis study utilized data from the mixed retrospective and prospective NYC 4H cohort, comprised of adult individuals with confirmed HIV and HF from inpatient or clinic visits between July 2017 and June 2022. from eleven major New York City Health and Hospitals. Racial identification was reported by the patients. Social adversities (SA) were assessed through a psychosocial evaluation conducted by licensed clinical social workers (LCSWs) during the initial clinic or hospital encounter within the enrollment period. Each patient's home address was mapped to the area deprivation index (ADI) to obtain ADI ranking and further characterize socioeconomic disadvantage. We assessed the relationship between social adversities and overall mortality in each racial group using hazard ratios (HRs) derived from proportional hazard regression models.

resultsIn total, 1044 patients, including 631 Black/African American, 289 Hispanic/Latino, 57 non-Hispanic White, 17 Asian/Pacific Islander, and 50 of unknown or other racial backgrounds were analyzed in the study. An average follow-up time is 3.8 years. Significant racial difference in ischemic cardiomyopathy, with the highest occurrence found in the Black/African American group (51%) were noticed comparing to Asian/Pacific Islander (2.3%) and Other/Unknown groups (5.6%) (P < 0.001). The rate of coronary artery bypass grafting (CABG) among the African American population (1.9%) is notably lower (P < 0.001) compared to other racial groups. Based on state-wide ADI ranking, all patients disproportionately clustered in the most disadvantaged neighborhood areas, however patients identifying as Black/African American and Hispanic/Latino were more likely to reside in areas with higher ADI score. Asian/Pacific Islander populations have experienced fewer social adversities, with 76.5% reporting no encounters with social adversity, compared to 41% for Black/African American, 44.3% for Hispanic/Latino, 45.6% for non-Hispanic White, and 34% for Other/Unknown groups. Non-Hispanic White group exhibited a higher prevalence of LGBTQ individuals at 10.5%, a identity not commonly listed among the top challenge for other racial groups (P = 0.002). During the follow-up period, a total of 259 deaths were recorded. The mortality rate is lowest in Asian/Pacific Islanders (11.8%), while comparing to non-Hispanic Whites (33.3%) and unknown or other races (50%).

conclusionsSignificant differences exist in comorbidities, disease management, and social conditions among HIV and heart failure patients across five racial groups. The findings suggest that within impoverished multiethnic communities, it is crucial to conduct comprehensive screenings for social adversities across all racial groups, as social disadvantage may manifest in various ways.

Indexed as

Healthcare DisparitiesHeart FailureHIV InfectionsAdultAsianBlack or African AmericanCohort StudiesFemaleHispanic or LatinoHumansMaleMiddle AgedNew York CityProspective StudiesRetrospective StudiesSocioeconomic Disparities in Health

Identifiers

PMID41801860
PMCPMC12970931

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.